Share This Post

Business Wire

Kiromic Announces Identification of Novel Targets for Allogeneic CAR Gamma Delta T-cell Therapy in Solid Tumors Utilizing Kiromic’s Proprietary Artificial Intelligence Engine

HOUSTON–(BUSINESS WIRE)—- $KRBP #AI–Kiromic announces Identification of Novel Targets for Allogeneic CAR Gamma Delta T-cell Therapy in Solid Tumors Utilizing Proprietary AI Engine

Share This Post